Superparamagnetic Iron Oxide Nanoparticle–Aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
Top Cited Papers
- 5 September 2008
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 3 (9), 1311-1315
- https://doi.org/10.1002/cmdc.200800091
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Thermally Cross-Linked Superparamagnetic Iron Oxide Nanoparticles: Synthesis and Application as a Dual Imaging Probe for Cancer in VivoJournal of the American Chemical Society, 2007
- Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy TransferNano Letters, 2007
- ErbB receptors: from oncogenes to targeted cancer therapiesJCI Insight, 2007
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences of the United States of America, 2006
- Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study GroupBlood, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerThe New England Journal of Medicine, 2005
- Sensitive, Noninvasive Detection of Lymph Node MetastasesPLoS Medicine, 2004
- PET and [18F]-FDG in oncology: A clinical updateNuclear Medicine and Biology, 1996
- Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluidsInternational Journal of Cancer, 1995
- Original Articles: Prostate Cancer: The Use and Accuracy of Cross-Sectional Imaging and Fine Needle Aspiration Cytology for Detection of Pelvic Lymph Node Metastases Before Radical ProstatectomyJournal of Urology, 1995